
Source externe
Medical Xpress – Actualités Santé
Mapping Deep South counties links higher diabetes rates to poverty and food insecurity
Counties where residents suffer from higher diabetes rates across the Deep South often also face greater poverty, food insecurity and barriers to health care and physical activity, a new University of Mississippi study reveals.
le 10 nov. 2026· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Intensive blood pressure therapy did not cut cardiovascular events in adults with diabetes
Intensive blood pressure-lowering treatment to reduce systolic pressure below 120 mm Hg in adults with type 2 diabetes, who are at increased risk of cardiovascular events, did not significantly reduce the incidence of cardiovascular death, stroke, heart attack or other…
le 9 nov. 2026· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
New surface coating could help implants bond better with bone in people with diabetes
Flinders University researchers are launching an innovative surface-engineering technology that could help to raise the performance of implantable medical devices in people with diabetes and other metabolic diseases.
le 9 nov. 2026· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Researchers identify blood-based biomarkers that could help personalize treatment for autoimmune diabetes
Researchers at Bar-Ilan University's Azrieli Faculty of Medicine have identified blood biomarkers that accurately predict which mice would respond to an experimental combination therapy for latent autoimmune diabetes in adults (LADA), a form of autoimmune diabetes that is…
le 9 nov. 2026· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
GLP-1 drugs show lower obesity-related cancer risk than insulin, but not all diabetes treatments
Years of research point to obesity and type 2 diabetes raising the risk of developing several types of cancer. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a recent medical breakthrough, were originally developed for blood sugar control or diabetes management and also…
le 9 nov. 2026· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Two-year study will examine how gender-affirming hormone therapy affects energy use and blood vessel function
The research team at the LeiCeM Cluster of Excellence is preparing a new study. It builds on the first phase of the Hormones and Health study (HHS), in which researchers from the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), Leipzig University and…
le 9 nov. 2026· Endocrinologie-DiabétologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
A little-known protein could be a major culprit in type 2 diabetes
Scientists have discovered that a buildup of a protein called Miro1 may be a hidden driver of insulin resistance in Type 2 diabetes, with preclinical experiments showing that removing it restores the muscles’ response to insulin. Exercise was also found to lower Miro1 levels in…
le 9 nov. 2026· Endocrinologie-DiabétologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
New diabetes implant uses electricity to lower blood sugar and promote weight loss
Researchers have developed a remarkable new electronic implant that could transform type 2 diabetes treatment by lowering blood sugar without insulin or traditional drugs. The device uses a special electrically powered catalyst to convert excess glucose into a substance that the…
le 2 nov. 2026· Endocrinologie-DiabétologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
Type 2 diabetes breakthrough as 54% achieve remission in just 6 months
A promising new study suggests that more than half of younger adults with type 2 diabetes could achieve remission in just six months through a combination of a low-calorie diet and structured exercise. Researchers found that 54% of participants under age 45 who followed an…
le 30 oct. 2026· Endocrinologie-DiabétologieLire chez la source
Source externe
FDA – Press Releases
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week.
le 20 oct. 2026· Endocrinologie-DiabétologieLire chez la source
← Plus récentes
Page 2 sur 2
